drugset / Trial / NCT02035878

Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression

NCT02035878

Phase 2 Unknown 75 enrolled Acadia University
RandomizedCrossoverDouble-blindTreatment

Summary

The proposed project will investigate the effects of probiotics on anxiety and associated psychological and physiological factors in humans. The therapeutic potential of probiotics for reducing anxiety and other factors associated with a disrupted microbiome will be assessed in a double-blind placebo-crossover design. Based on the research findings to date, it is hypothesized that probiotics will reduce anxiety and depressive symptoms.

Timeline

Start
2012-08
Primary completion
2013-10
Completion
2014-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Probiotics Other / unclassified 400 mg Oral